A Phase I/Ii Trial of Ibrutinib, Intratumoral CPG and Local Radiation in Patients With Low-Grade B-Cell Lymphoma: Interim Clinical and Correlative Results
Hematological Oncology - United Kingdom
doi 10.1002/hon.82_2629
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley